Gains on chromosome arm 9q represent a novel and independent marker of adverse prognosis in multiple myeloma patients receiving upfront high-dose chemotherapy and autologous stem cell transplantation.

被引：0
作者：
Liebisch, P
Benner, A
Tschajka, K
Wendl, C
Goldschmidt, H
Döhner, H
机构：
[1] Univ Hosp Ulm, Dept Internal Med 3, Ulm, Germany
[2] German Canc Res Ctr, Cent Unit Biostat, Heidelberg, Germany
[3] Univ Hosp Heidelberg, Med Klin 5, Heidelberg, Germany
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1559
引用
收藏
页码：447A / 447A
页数：1
相关论文
共 50 条
[21]   Secondary Primary Malignancies in Patients with Multiple Myeloma Treated with High-Dose Chemotherapy and Autologous Blood Stem Cell Transplantation [J].
Fenk, Roland ;
Neubauer, Florian ;
Bruns, Ingmar ;
Saure, Christian ;
Schroeder, Thomas ;
Germing, Ulrich ;
Gattermann, Norbert ;
Haas, Rainer ;
Kobbe, Guido .
BLOOD, 2011, 118 (21) :1745-1746
[22]   Secondary primary malignancies in patients with multiple myeloma treated with high-dose chemotherapy and autologous blood stem cell transplantation [J].
Fenk, Roland ;
Neubauer, Florian ;
Bruns, Ingmar ;
Schroeder, Thomas ;
Germing, Ulrich ;
Haas, Rainer ;
Kobbe, Guido .
BRITISH JOURNAL OF HAEMATOLOGY, 2012, 156 (05) :683-686
[23]   High-dose chemotherapy and autologous peripheral blood stem cell transplantation in high-risk multiple myeloma [J].
Murakami, H ;
Fujii, H ;
Inaba, T ;
Shimazaki, C ;
Okamoto, S ;
Miwa, A ;
Sawamura, M ;
Abe, M ;
Chou, T ;
Asaoku, H ;
Kitahara, Y ;
Hayashi, K ;
Kosaka, M ;
Togawa, A ;
Takatsuki, K .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2004, 73 (03) :169-173
[24]   High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma [J].
Alexandra Gomez-Arteaga ;
Tomer M. Mark ;
Danielle Guarneri ;
Paul J. Christos ;
Usama Gergis ;
June D. Greenberg ;
Jingmei Hsu ;
Sebastian A. Mayer ;
Ruben Niesvizky ;
Roger N. Pearse ;
Adrienne A. Phillips ;
Adriana Rossi ;
Morton Coleman ;
Koen van Besien ;
Tsiporah B. Shore .
Bone Marrow Transplantation, 2019, 54 :2027-2038
[25]   High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma [J].
Gomez-Arteaga, Alexandra ;
Mark, Tomer M. ;
Guarneri, Danielle ;
Christos, Paul J. ;
Gergis, Usama ;
Greenberg, June D. ;
Hsu, Jingmei ;
Mayer, Sebastian A. ;
Niesvizky, Ruben ;
Pearse, Roger N. ;
Phillips, Adrienne A. ;
Rossi, Adriana ;
Coleman, Morton ;
van Besien, Koen ;
Shore, Tsiporah B. .
BONE MARROW TRANSPLANTATION, 2019, 54 (12) :2027-2038
[26]   First-line tandem high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies [J].
Naumann-Winter, Frauke ;
Greb, Alexander ;
Borchmann, Peter ;
Bohlius, Julia ;
Engert, Andreas ;
Schnell, Roland .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (10)
[27]   Cryotherapy Reduces Mucositis in Multiple Myeloma Patients Receiving High-Dose Melphalan Conditioning Prior to Autologous Stem Cell Transplantation [J].
Rodriguez, Mabel ;
Adel, Nelly G. ;
Devlin, Sean ;
Giralt, Sergio A. ;
Landau, Heather .
BLOOD, 2012, 120 (21)
[28]   Prognostic Value of Bone Marrow Angiogenesis in Patients with Multiple Myeloma Undergoing High-Dose Therapy and Autologous Stem Cell Transplantation. [J].
Pokrovskaya, Olga ;
Mendeleeva, Larisa ;
Kaplanskaya, Irina ;
Parovichnikova, Elena ;
Kulikov, Sergei ;
Savchenko, Valeryi .
BLOOD, 2008, 112 (11) :1141-1141
[29]   Progress in treating patients with multiple myeloma. High-dose chemotherapy and stem cell transplantation [J].
Einsele, H. ;
Knop, S. ;
Straka, C. .
ONKOLOGE, 2010, 16 (03) :263-+
[30]   Cellular in vitro immune function in multiple myeloma patients after high-dose chemotherapy and autologous peripheral stem cell transplantation [J].
M Lindemann ;
P Schuett ;
T Moritz ;
H D Ottinger ;
B Opalka ;
S Seeber ;
M R Nowrousian ;
H Grosse-Wilde .
Leukemia, 2005, 19 :490-492
12345